{"id":"W4360998472","doi":"10.1016/j.annonc.2023.02.008","title":"VP2-2023: Dostarlimab+chemotherapy for the treatment of primary advanced or recurrent (A/R) endometrial cancer (EC): A placebo (PBO)-controlled randomised phase III trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Carboplatin; Population; Clinical endpoint; Placebo; Discontinuation; Paclitaxel; Phases of clinical research; Endometrial cancer; Oncology; Cancer; Chemotherapy; Randomized controlled trial; Cisplatin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009641346,0.00132298,0.002169886,0.0003631435,0.0002855792,0.0008511653,0.0008612715,0.001172234,0.0114094],"category_scores_gemma":[0.0007473511,0.0004568373,0.001444292,0.0003738038,0.0008670982,0.00067173,0.0003563517,0.00283167,0.001337173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000556555,"about_ca_system_score_gemma":0.0009499223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001530092,"about_ca_topic_score_gemma":0.003930431,"domain_scores_codex":[0.9997628,0.0001183335,0.00001027717,0.00004328859,0.0000167101,0.00004866208],"domain_scores_gemma":[0.9996885,0.00007180982,0.00005271133,0.00001996556,0.00001400688,0.0001530243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9462326,0.004075659,0.0004336049,0.001336229,0.0009258599,0.00004455874,0.00004020747,0.0004689786,0.004686954,0.0002284792,0.001948356,0.03957856],"study_design_scores_gemma":[0.941384,0.05482261,0.001389392,0.00005044249,0.0003180116,0.00004439359,0.00002276768,0.0002788382,0.0003854878,0.0001425452,0.001150795,0.00001073706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.962933,0.01919878,0.00101068,0.001327529,0.001231266,0.003885413,0.003080862,0.0003961545,0.006936347],"genre_scores_gemma":[0.9706237,0.009196886,0.002067348,0.001867583,0.000581565,0.00281395,0.002878476,0.00006522452,0.009905195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0114094,"threshold_uncertainty_score":0.03816825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1253769369910346,"score_gpt":0.4450653267402925,"score_spread":0.319688389749258,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}